Contact

What are you looking for?

Maine signs into law measure to amend the state’s PFAS in products statute

SafeGuardSHardgoodsJune 27, 2023

SG 73/23

The amendment postpones the notification deadline and gives manufacturers more options on how to report.

Maine’s governor signed into law LD 217 on June 8, 2023. The measure clarifies and improves provisions set out by 38 M.R.S. §1614 ‘Products Containing PFAS’ (SGS SafeGuard). The changes made are applied retroactively to the law from January 1, 2023.

In the meantime, the Maine Department of Environmental Protection (DEP) is working to finalize a rule under the 38 M.R.S. §1614 ‘Products Containing PFAS’ law, which would clarify disclosure requirements and establish a virtual notification tool (SG 28/33).

Table 1 highlights the changes LD 217 implements.

Comparison between 38 M.R.S. § 1614. Products Containing PFAS and respective amendments under LD 217

ClauseLD 217 amending 38 M.R.S. § 1614. Products Containing PFAS38 M.R.S. § 1614. Products Containing PFAS
Notification requirement of intentionally added PFASReporting required by Jan 1st, 2025Reporting required by Jan 1st, 2023
Reporting of PFAS by CAS number or in the absence of this number a description approved by the DEPReporting of PFAS by CAS number
Reporting as exact quantity of each PFAS compound or if not available as the amount of Total Organic Fluorine (TOF) determined by analytical testing or based on supplier informationReporting as exact quantity of each PFAS compound determined by analytical testing
Manufacturers employing 25 or less people are exempt from notification requirementsNo exemption based on business size
ExemptionsExemption of used products or products componentsNo exemption of used products or products components

With facilities accredited to ISO, Australian, European and US standards, and experts covering every region of the globe, SGS is the number one choice for accurate, innovative solutions to PFAS testing. Whether you require rapid turnaround times, short-list remediation analysis or wider investigations of tissue and serum matrices, we have the capabilities to ensure your project is accurately and efficiently completed. Contact us for more information on PFAS testing or visit our website. In the end, it’s only trusted because it’s tested.

© SGS Société Générale de Surveillance SA. This publication or website is a property of SGS Société Générale de Surveillance SA. All contents including website designs, text, and graphics contained herein are owned by or licensed to SGS Société Générale de Surveillance SA. The information provided is for technical and general information purposes only and offers no legal advice. The information is no substitute for professional legal advice to ensure compliance with the applicable laws and regulations. All information is provided in good faith “as is”, and SGS Société Générale de Surveillance SA makes no representation or warranty of any kind, express or implied, and does not warrant that the information will be error-free or meet any particular criteria of performance or quality.

Related Services

For further information, please contact:

Melanie Schubert

Melanie Tamayo

Senior Technical Manager
SGS North America
Udo Krischke

Dr. Udo Krischke

Global Manager RSTS & FCM Business Development Manager

News & Insights

  • SGS SafeGuardS

1 Place des Alpes,

P.O. Box 2152, 1211,

Geneva, Switzerland